GlassScriptPhysician profile
Cynthia E Gavilanes
NPI 1629178983
$7,472.31
in general payments reported to CMS, 2019-2025
37 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,126 · 2022: $1,477 · 2023: $1,944 · 2024: $1,372 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,859 · Travel and Lodging: $450 · Consulting Fee: $398 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,859.36 |
| Travel and Lodging | $449.96 |
| Consulting Fee | $397.50 |
| Education | $162.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,510.07 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Myriad Genetic Laboratories, INC. | $870.55 | 2021-2025 | Prolaris |
| Boston Scientific Corporation | $549.98 | 2021-2025 | Axonics |
| Astellas Pharma US INC | $483.86 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Axonics, INC. | $475.68 | 2021-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $435.47 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $414.03 | 2023 | |
| Pfizer INC. | $302.93 | 2021-2025 | |
| Abbvie INC. | $289.88 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $257.40 | 2023-2025 | Gemtesa |
| Verity Pharmaceuticals INC. | $255.06 | 2021-2025 | Trelstar, Tlando |
| Rochester Medical Corporation | $243.46 | 2021 | |
| Merck Sharp & Dohme LLC | $171.29 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Urovant Sciences INC | $158.24 | 2022 | |
| Endo Pharmaceuticals INC. | $140.79 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $125.13 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $105.15 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $87.91 | 2023 | Lynparza |
| Myovant Sciences INC. | $86.34 | 2021 | |
| Ferring Pharmaceuticals INC. | $67.70 | 2025 | Adstiladrin |
| Coloplast Corp | $59.99 | 2021-2023 | Titan |
| Dendreon Pharmaceuticals LLC | $48.69 | 2025 | Provenge |
| Merz North America, INC. | $47.73 | 2022 | |
| Urogen Pharma, INC. | $40.16 | 2022-2025 | |
| Telix Pharmaceuticals | $30.38 | 2025 | Illuccix |
| Convatec INC. | $26.18 | 2023 | |
| Halozyme INC | $24.09 | 2023 | |
| Vivus LLC | $20.90 | 2025 | Pancreaze |
| Medtronic, INC. | $19.95 | 2024 | Interstim |
| Olympus America INC. | $19.00 | 2024 | Itind System |
| Antares Pharma, INC. | $17.48 | 2021 | |
| Procept Biorobotics Corporation | $17.33 | 2025 | |
| Lilly USA, LLC | $15.34 | 2025 | Zepbound, Mounjaro |
| Becton, Dickinson and Company | $14.91 | 2024 | Bard Urinary Drainage Bag |
| Clarus Therapeutics INC. | $14.40 | 2021 | |
| Foundation Medicine, INC. | $13.82 | 2023 | |
| Mission Pharmacal Company | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Gavilanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.